The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.
Division of Gastroenterology, Leuven University Hospitals, 49 Herestraat, BE 3000, Leuven, Belgium. Gert.vanassche@uzleuven.be
Gert
G
Van Assche
Axel
A
Dignass
Walter
W
Reinisch
C Janneke
CJ
van der Woude
Andreas
A
Sturm
Martine
M
De Vos
Mario
M
Guslandi
Bas
B
Oldenburg
Iris
I
Dotan
Philippe
P
Marteau
Alessandro
A
Ardizzone
Daniel C
DC
Baumgart
Geert
G
D'Haens
Paolo
P
Gionchetti
Francisco
F
Portela
Boris
B
Vucelic
Johan
J
Söderholm
Johanna
J
Escher
Sibylle
S
Koletzko
Kaija-Leena
KL
Kolho
Milan
M
Lukas
Christian
C
Mottet
Herbert
H
Tilg
Séverine
S
Vermeire
Frank
F
Carbonnel
Andrew
A
Cole
Gottfried
G
Novacek
Max
M
Reinshagen
Epameinondas
E
Tsianos
Klaus
K
Herrlinger
Bas
B
Oldenburg
Yoram
Y
Bouhnik
Ralf
R
Kiesslich
Eduard
E
Stange
Simon
S
Travis
James
J
Lindsay
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000636:Aminosalicylic Acids / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001168:Arthritis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D002648:Child; D000529:Complementary Therapies; D003424:Crohn Disease / Q000150:complications / Q000175:diagnosis* / Q000523:psychology / Q000628:therapy*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000069285:Infliximab; D007412:Intestinal Fistula / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D008297:Male; D011247:Pregnancy; D011248:Pregnancy Complications / Q000628:therapy; D011613:Psychotherapy; D011687:Purines / Q000627:therapeutic use; D012008:Recurrence; D012871:Skin Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000305:Adrenal Cortex Hormones; D000636:Aminosalicylic Acids; D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D011687:Purines; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab